New MRI technique could reveal how well lung scarring drugs work
NCT ID NCT05241275
First seen Oct 01, 2025 · Last updated Apr 29, 2026 · Updated 23 times
Summary
This study tests whether a special type of MRI (using xenon gas) can measure how well anti-fibrotic medications work in people with progressive lung scarring. About 60 adults with certain types of interstitial lung disease will have MRI scans before starting treatment and again at 3, 6, and 12 months. The goal is to see if the MRI can detect changes in lung function earlier or more precisely than standard tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.